Issued Patents All Time
Showing 51–75 of 124 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8114884 | CXCR4 antagonists for the treatment of medical disorders | Hyunsuk Shim, James P. Snyder, Weiqiang Zhan, Zhongxing Liang | 2012-02-14 |
| 8114994 | 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment viral infections and abnormal cellular proliferation | Shuli Mao, Michael Hager, Raymond F. Schinazi | 2012-02-14 |
| 8080659 | CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders | James P. Snyder, Weiqiang Zhan | 2011-12-20 |
| 8067424 | Selective inhibitors for cyclin-dependent kinases | Ashutosh S. Jogalekar, James P. Snyder, Anthony Barrett, Raoul C. Coombes, Simak Ali +3 more | 2011-11-29 |
| 8008312 | CXCR4 antagonists for the treatment of HIV infection | Hyunsuk Shim, James P. Snyder, Weiqiang Zhan, Zhongxing Liang | 2011-08-30 |
| 7842705 | Curcumin analogs with anti-tumor and anti-angiogenic properties | James P. Snyder, Matthew C. Davis, Brian Adams, Mamoru Shoji, Eva M. Ferstl +1 more | 2010-11-30 |
| 7662938 | 2′-fluoronucleosides | Raymond F. Schinazi, Chung K. Chu, J. Jeffrey McAtee, Junxing Shi, Yongseok Choi +2 more | 2010-02-16 |
| 7635690 | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine | Raymond F. Schinazi, Jennifer Hammond, John W. Mellors | 2009-12-22 |
| 7557139 | Triptolide analogs for the treatment of autoimmune and inflammatory disorders | Hariharan Venkatesan, James P. Snyder, Susheng Wang | 2009-07-07 |
| 7495006 | 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation | Shuli Mao, Michael Hager | 2009-02-24 |
| 7468436 | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers | Raymond F. Schinazi, Woo-Baeg Choi | 2008-12-23 |
| 7419966 | [5-carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides | Raymond F. Schinazi | 2008-09-02 |
| 7402588 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane | Raymond F. Schinazi, Woo-Baeg Choi | 2008-07-22 |
| 7375136 | pH-dependent NMDA receptor antagonists | Stephen F. Traynelis, James P. Snyder, Yesim Altas, David D. Mott, James J. Doherty +1 more | 2008-05-20 |
| 7371766 | Curcumin analogs with anti-tumor and anti-angiogenic properties | James P. Snyder, Matthew C. Davis, Brian Adams, Mamoru Shoji, Eva M. Ferstl +1 more | 2008-05-13 |
| 7307065 | 2′-Fluoronucleosides | Raymond F. Schinazi, Chung K. Chu, J. Jeffrey McAtee, Junxing Shi, Yongseok Choi +2 more | 2007-12-11 |
| 7160999 | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers | Raymond F. Schinazi, Woo-Baeg Choi | 2007-01-09 |
| 7115584 | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine | Raymond F. Schinazi, Jennifer Hammond, John W. Mellors | 2006-10-03 |
| 7053100 | Therapeutic nucleosides | — | 2006-05-30 |
| 6939965 | Process of manufacture of 1,3-oxathiolane nucleosides using titanium trichloride mono-isopropoxide | George R. Painter, Merrick R. Almond, Darryl G. Cleary, Josè D. Soria, Marcos Sznaidman | 2005-09-06 |
| 6911424 | 2′-fluoronucleosides | Raymond F. Schinazi, Chung K. Chu, J. Jeffrey McAtee, Junxing Shi, Yongseok Choi +2 more | 2005-06-28 |
| 6812233 | Therapeutic nucleosides | — | 2004-11-02 |
| 6777441 | Triptolide analogs for the treatment of autoimmune and inflammatory disorders | Susheng Wang, James P. Snyder, Hariharan Venkatesan | 2004-08-17 |
| 6750211 | Diimino compounds for use as modulators of cell regulation | Alfred H. Merrill, Jr., Lisa Warden | 2004-06-15 |
| 6720184 | Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination | Alfred H. Merrill, Jr., Elaine Wang, Ronald T. Riley | 2004-04-13 |